Mal-PEG8-Phe-Lys-PAB-Exatecan (compound 15) is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631) composition[1].
IC 50
Camptothecins
References
[1] Manel KRAIEM. Treatment of cancer. Patent WO2021151984A1.
